Status | Study |
Recruiting |
Study Name: CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Condition: Peripheral T-Cell Lymphoma Angioimmunoblastic T Cell Lymphoma Date: 2015-07-18 Interventions: Drug: CEOP/IVE/GDP chemotherapy regimen |
Completed |
Study Name: Study of Orally Administered AG-221 in Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Subjects With Advanced Solid Tumors, Including Glioma, and With Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation Condition: Solid Tumor Glioma Angioimmunoblasti Date: 2014-10-16 Interventions: Drug: AG-221 AG-221 administered orally on every day of 28 day cycles until disease progression or unacc |
Recruiting |
Study Name: Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma Condition: Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Date: 2014-09-03 Interventions: Drug: romidepsin Given IV |
Recruiting |
Study Name: Romidepsin in Combination With CHOEP as First Line Treatment Before Hematopoietic Stem Cell Transplantation in Young Patients With Nodal Peripheral T-cell Lymphomas: a Phase I-II Study Condition: Peripheral T-cell Lymphomas (PTCL) PTCL-NOS Date: 2014-07-21 Interventions: Drug: Ro-CHOEP-21 (PHASE I) |
Recruiting |
Study Name: CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma Condition: Adult Lymphocyte Depletion Hodgkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Date: 2014-06-18 Interventions: Drug: 6,8-bis(benzylthio)octanoic acid |
Completed |
Study Name: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-10-08 Interventions: Drug: busulfan Given IV |
Recruiting |
Study Name: Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia With 11q23 (MLL) Date: 2013-04-22 Interventions: Biological: therapeutic allogeneic lymphocytes |
Completed |
Study Name: Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-27 Interventions: Drug: brentuximab vedotin Give |
Recruiting |
Study Name: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Condition: Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Date: 2013-02-13 Interventions: Other: questionnaire administration |
Recruiting |
Study Name: Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency Condition: Aggressive Non-Hodgkin Lymphoma Anaplastic Large Cell Lymphoma Date: 2013-02-06 Interventions: Dietary Supplement: Cholecalciferol |